Thus, Jak1 deletion directly averts PD-L1 protein expression, devoiding the tumor cell of a primary target of immune checkpoint blockade, and suppresses T cell infiltration in the tumor microenvironment (TME) [23]. The gene discussed is JAK1; the disease is neoplasm.